Skip to main content
NCBI home page
AAPS PharmSciTech logoLink to AAPS PharmSciTech
. 2015 Feb 19;3(3):72–76. doi: 10.1007/BF02830623

Preparation of gelatin microbeads with a narrow size distribution using microchannel emulsification

Satoshi Iwamoto 1,2,✉, Kei Nakagawa 1, Shinji Sugiura 1, Mitsutoshi Nakajima 1,✉
PMCID: PMC2784054  PMID: 12916940

Abstract

The purpose of this study was to prepare monodisperse gelatin microcapsules containing an active agent using microchannel (MC) emulsification, a novel technique for preparing water-in-oil (W/O) and oil-in-water (O/W) emulsions. As the first step in applying MC emulsification to the preparation of monodisperse gelatin microcapsules, simple gelatin microbeads were prepared using this technique. A W/O emulsion with a narrow size distribution containing gelatin in the aqueous phase was created as follows. First, the aqueous disperse phase was fed into the continuous phase through the MCs at 40°C (operating pressure: 3.9 kPa). The emulsion droplets had an average particle diameter of 40.7 μm and a relative standard deviation of 5.1%. The temperature of the collected emulsion was reduced and maintained at 25°C overnight. The gelatin microbeads had a smooth surface after overnight gelation; the average particle diameter was calculated to be 31.6 μm, and the relative standard deviation, 7.3%. The temperature was then lowered to 5°C by rapid air cooling and finally dried. The gelatin beads were dried and could be resuspended well in iso-octane. The had an average particle diameter of 15.6 μm, and a relative standard deviation of 5.9%. Using MC emulsification, we were able to prepare gelatin microbeads with a narrow size distribution. Since this emulsification technique requires only a low-energy input, it may create desirable experimental conditions for microencapsulation of unstable substances such as peptides and proteins. This method is promising for making monodisperse microbeads.

Keywords: gelatin, beads, microcapsule, MC emulsification, narrow size distribution

Full Text

The Full Text of this article is available as a PDF (641.2 KB).

References

  • 1.Djabourov M, Leblond J, Papon P. Gelatin of aqueous gelatin solutions, I: structural investigation. J Phys France. 1988;49:319–332. doi: 10.1051/jphys:01988004902031900. [DOI] [Google Scholar]
  • 2.Michon C, Cuvelier G, Relkin P, Launay B. Influence of thermal history on the stability of gelatin gels. Int J Biol Macromolecul. 1997;20:259–264. doi: 10.1016/S0141-8130(97)00024-X. [DOI] [PubMed] [Google Scholar]
  • 3.Pezron I, Djabourov M, Leblond J. Conformation of gelatin chains in aqueous solutions, I: a light and small-angle neutron scattering study. Polymer. 1991;32:3201–3210. doi: 10.1016/0032-3861(91)90143-7. [DOI] [Google Scholar]
  • 4.Vandelli MA, Rivasi F, Guerra P, Forni F, Arletti R. Gelatin microspheres crosslinked with D, L-glyceraldehyde as a potential drug delivery system: preparation, characterisation, in vitro and in vivo studies. Int J Pharm. 2001;215:175–184. doi: 10.1016/S0378-5173(00)00681-5. [DOI] [PubMed] [Google Scholar]
  • 5.Vinetsky Y, Magdassi S. Formation and surface properties of microcapsules based on gelatin-sodium dodecyl sulphate interactions. Colloids Surf A. 1997;122:227–235. doi: 10.1016/S0927-7757(96)03753-3. [DOI] [Google Scholar]
  • 6.Berkland C, Kim K, Pack D. Fabrication of PLG microspheres with precisely controlled and monodisperse size distributions. J Control Release. 2001;73:59–74. doi: 10.1016/S0168-3659(01)00289-9. [DOI] [PubMed] [Google Scholar]
  • 7.Washington C. Drug release from microparticulate systems. In: Benita S, editor. Microencapsulation. New York, NY: Marcel Dekker; 2002. pp. 155–181. [Google Scholar]
  • 8.Goosen MFA. Mass transfer in immobilized cell systems. In: Kühltreiber WM, Lanza RP, Chick WL, editors. Cell Encapsulation Technology and Therapeutics. Boston, MA: Birkhäuser; 1999. pp. 18–28. [Google Scholar]
  • 9.Young TJ, Johnston KP, Mishima K, Tanaka H. Encapsulation of lysozyme in a biodegradable polymer by precipitation with a vapor-overliquid antisolvent. J Pharm Sci. 1999;88(6):640–650. doi: 10.1021/js980237h. [DOI] [PubMed] [Google Scholar]
  • 10.Lacasse FX, Hildgen P, Perodin J, Escher E, Phillips NC, McMullen JN. Improved activity of a new angiotensin receptor antagonist by an injectable spray-dried polymer microsphere preparation. Pharm Res. 1997;14(7):887–891. doi: 10.1023/A:1012147700014. [DOI] [PubMed] [Google Scholar]
  • 11.Eldem T, Speiser P, Hincal A. Optimization of spray-dried and-congealed lipid micropellets and characterization of their surface morphology by scanning electron microscopy. Pharm Res. 1991;8:47–54. doi: 10.1023/A:1015874121860. [DOI] [PubMed] [Google Scholar]
  • 12.Eldem T, Speiser P, Hincal A. Polymorphic behavior of sprayed lipid micropellets and its evaluation by differential scanning calorimetry and scanning electron microscopy. Pharm Res. 1991;8:178–184. doi: 10.1023/A:1015831801813. [DOI] [PubMed] [Google Scholar]
  • 13.Luck M, Pistel KF, Li YX, Blunk T, Muller RH, Kissel T. Plasma protein adsorption on biodegradable microspheres consisting of poly (D, L-lactide-co-glycolide), poly(L-lactide) or ABA triblock copolymers containing poly(oxy-ethylene): influence of production method and polymer composition. J Control Release. 1998;55:107–120. doi: 10.1016/S0168-3659(98)00030-3. [DOI] [PubMed] [Google Scholar]
  • 14.Kawashima Y, Yamamoto H, Takeuchi H, Hino T, Niwa T. Properties of a peptide containing D, L-lactide/glycolide copolymer nanospheres prepared by novel emulsion solvent diffusion methods. Eur J Pharm Biopharm. 1998;45:41–48. doi: 10.1016/S0939-6411(97)00121-5. [DOI] [PubMed] [Google Scholar]
  • 15.Sturesson C, Carifors J. Incorporation of protein in PLG-microspheres with retention of bioactivity. J Control Release. 2000;67:171–178. doi: 10.1016/S0168-3659(00)00205-4. [DOI] [PubMed] [Google Scholar]
  • 16.Tinsley-Bown AM, Fretwell R, Dowsett AB, Davis SL, Farrar GH. Formulation of poly(D, L-lactic-co-glycolic acid) microparticles for rapid plasmid DNA delivery. J Control Release. 2000;66:229–241. doi: 10.1016/S0168-3659(99)00275-8. [DOI] [PubMed] [Google Scholar]
  • 17.Kawakatsu T, Kikuchi Y, Nakajima M. Regular-sized cell creation in microchannel emulsification by visual microprocessing method. J Am Oil Chem Soc. 1997;74:317–321. doi: 10.1007/s11746-997-0143-8. [DOI] [Google Scholar]
  • 18.Sugiura S, Nakajima M, Ushijima H, Yamamoto K, Seki M. Preparation characteristics of monodispersed water-in-oil emulsions using microchannel emulsification. J Chem Eng Jpn. 2001;34:757–765. doi: 10.1252/jcej.34.757. [DOI] [Google Scholar]
  • 19.Kawakatsu T, Trägårdh G, Trägårdh C, Nakajima M, Oda N, Yonemoto T. The effect of the hydrophobicity of microchannels and components in water and oil phases on droplet formation in micro-channel water-in-oil emulsification. Colloids Surf A. 2001;179:29–37. doi: 10.1016/S0927-7757(00)00498-2. [DOI] [Google Scholar]
  • 20.Joscelyne S, Trägårdh G. Membrane emulsification: a literature review. J Membrane Sci. 2000;169:107–117. doi: 10.1016/S0376-7388(99)00334-8. [DOI] [Google Scholar]
  • 21.Sugiura S, Nakajima M, Iwamoto S, Seki M. Interfacial tension driven monodispersed droplet formation from microfabricated channel array. Langmuir. 2001;17:5562–5566. doi: 10.1021/la010342y. [DOI] [Google Scholar]
  • 22.Hildebrand GE, Tack JW. Microencapsulation of peptides and proteins. Int J Pharm. 2000;196:173–176. doi: 10.1016/S0378-5173(99)00415-9. [DOI] [PubMed] [Google Scholar]
  • 23.Takeuchi H, Yamamoto H, Kawashima Y. Mucoadhesive nanoparticulate systems for peptide drug delivery. Adv. Drug Deliv Rev. 2001;47:39–54. doi: 10.1016/S0169-409X(00)00120-4. [DOI] [PubMed] [Google Scholar]

Articles from AAPS PharmSciTech are provided here courtesy of American Association of Pharmaceutical Scientists

RESOURCES